Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2742236 | 0.87 | THRB (0.47) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL18499608 | 0.85 | THRB (0.50) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL11964329 | 0.81 | TSHR (0.51) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL17439214 | 0.81 | TSHR (0.47) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL13557333 | 0.80 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL13557337 | 0.80 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL4568739 | 0.80 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL2742241 | 0.80 | THRB (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL9963787 | 0.80 | THRB (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL13160588 | 0.80 | TSHR (0.54) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9244345-B1 | Non-ionic photo-acid generating polymers for resist applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2016-01-26 | — | — | US | disclosed |
| US-9244345-B1 | Non-ionic photo-acid generating polymers for resist applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2016-01-26 | — | — | US | disclosed |
| US-8329377-B2 | Imide compound and chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | IGF1R, CCNA1, MYC | THRB 3151/4885TSHR 2519/4885ALDH1A1 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.